Extreme Connect 2025
May 19-22
Paris, France
Learn More
Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO), specializes in biopharmaceuticals and advanced therapies for the treatment of patients with serious and rare diseases. With headquarters in Laupheim, Germany, and a site in Milford, Massachusetts, Rentschler Biopharma operates in a highly regulated environment, necessitating robust operational security and data integrity across its global infrastructure. Rentschler Biopharma worked with partner Scaltel in its journey to identify the best solution for improving network scalability and flexibility, leading them to work with Extreme.
Learn more about Rentschler Biopharma SE at www.rentschler-biopharma.com.